Search

Displaying all 3 results
DrugBest match

Mirikizumab

go.drugbank.com/drugs/DB14910
ApprovedInvestigational

Mirikizumab is a monoclonal antibody developed by Eli Lilly intended to treat ulcerative colitis. It inhibits the actions of interleukin-23 (IL-23), a pro-inflammatory cytokine that activates pathways contributing to the development of inflammatory diseases. Mirikizumab is approved in Japan and received a positive o...

  1. Indication

    Moderately to Severely Active Crohn's Disease

    go.drugbank.com/conditions/DBCOND0093405
    Drugs: Adalimumab · Infliximab · Mirikizumab · Upadacitinib
  2. Indication

    Moderately to Severely Active Ulcerative Colitis

    go.drugbank.com/conditions/DBCOND0105407
    Drugs: Adalimumab · Filgotinib · Infliximab · Mirikizumab · Ozanimod · Upadacitinib